Dissemination of 2014 dual antiplatelet therapy (DAPT) trial results: a systematic review of scholarly and media attention over 7 months.

1 In the USA, almost 700 000 stents are placed every year and there is an increasing trend for its use in Europe. 2 Dual antiplatelet therapy (DAPT) (ie, P2Y12-receptor inhibitor combined with aspirin) is recommended after placement of coronary stents to prevent thrombotic complications. 3 The optimal duration of DAPT has been debated. 4–8 In December 2014, the Harvard Clinical Research

also in 63,971 other papers